Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Independent UK
The Independent UK
National
Alex Woodward

FDA advisory panel to discuss additional Covid-19 boosters: What we know so far

AP

Drugmakers Pfizer and Moderna have filed applications for emergency use authorisation with the US Food and Drug Administration for a second “booster” dose of their Covid-19 vaccines, which an advisory panel for the federal agency is expected to discuss in April.

Pfizer is seeking approval for a second booster dose for people aged 65 and older, while Modern is seeking authorisation for a second booster for all adults.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.